FDA bans products from China plant used by Big Pharma players

Emily Wasserman A Chinese ingredient maker who has produced ingredients for some of the big guns in pharma including Novartis, Sanofi and Pfizer is getting its products banned by the ...

GlaxoSmithKline scientists accused of stealing drug R&D secrets for China scheme

John Carroll Yu Xue had a hard-earned reputation as a top chemist while she was working for GlaxoSmithKline in its Upper Merion, PA, facility. But Yu Xue–better known as Joyce–was ...

Pfizer expands consumer biz in China with Treerly supplements buy

Tracy Staton Pfizer's consumer health unit is said to be destined for sale, but that doesn't mean the business has stopped making its own buys. The drug giant snapped up ...

AstraZeneca spending hundreds of millions in China, blueprints new R&D hub

John Carroll FierceBiotech News

Will Glaxo’s peers follow its anti-corruption lead in China?

Carly Helfand GlaxoSmithKline, post-corruption scandal, has been working hard to clean up its act in China, overhauling its sales practices to wipe out bribery–and its general ...

Novartis CEO stands by emerging markets even as China economy continues to weaken

Eric Palmer China's economy is a mess and other emerging markets are flailing about as well. So what is pharma CEO to do if they have bet big on growth in the EM realm? Keep on ...

China slaps Pfizer with $500,000 in Viagra penalties for pharmacy tie-up

Emily Wasserman Pfizer has no problem keeping sales for Viagra flying high in China, where brand awareness campaigns and changing attitudes toward sex have given it a sizable hold on ...

Cold Genesys looks to China for a $10M cash infusion

Damian Garde Immuno-oncology biotech Cold Genesys raised a $ 10 million B round, rallying a stable of Chinese financiers as it moves forward with a late-stage cancer therapy. FierceBiotech ...

Apogenix inks cancer drug development deal for China

John Carroll Germany's Apogenix, which is backed by SAP co-founder Dietmar Hopp, has struck an exclusive licensing agreement with CANbridge Life Sciences to develop and commercialize ...

Argos gets a $40M China deal for AGS-003

John Carroll China's Lummy HK and the China BioPharma Capital I Fund have agreed to acquire $ 10 million worth of Durham, NC-based Argos Therapeutics stock in exchange for rights ...

Pfizer shutters vaccine sales business in China after Prevenar setback

Carly Helfand As it beefs up its vaccines business, Pfizer's looking to bolster revenue from the top-selling Prevenar family of shots. But on that front, it's come up against ...

Roche blueprints a $466M expansion in China

Damian Garde Roche is planning to make a major splash in China, looking to spend 450 million Swiss Francs ($ 466.2 million) to build a diagnostics operation in Suzhou. FierceBiotech ...
Page 1 of 812345...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS